drugset / Trial / NCT02246842
A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.
Treatment
Summary
The primary objective of the study was to compare peak serum anti-D levels (Cmax) of BPL's D-Gam® 1500 IU to Rhophylac® 1500IU in RhD-negative healthy volunteers.
Timeline
- Start
- 2004-05
- Primary completion
- 2004-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D-Gam® | Protein / enzyme biologic | 1500 iu | — |
| Comparator | Rhophylac® | Protein / enzyme biologic | 1500 iu | — |
Indications
No indication recorded.